Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VS-01 in Acute-on-chronic Liver Failure (ACLF)
NCT05900050Phase 2Terminated
- Sponsor
- Genfit
- Start
- Jul 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 2 trial of VS-01-HAC in acute-on-chronic liver failure (ACLF), ascites, sponsored by Genfit. Started Jul 2023; status: terminated.
02
Drugs
VS-01-HAC
03
Conditions
acute-on-chronic liver failure (ACLF)ascites
Beyond the preview
Go deeper on NCT05900050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05900050.